5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | NEUTRAL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.45▼ | 1.45▼ | 1.44▼ | 1.42▲ | 1.27▲ |
MA10 | 1.46▼ | 1.45▼ | 1.45▼ | 1.34▲ | 1.49▼ |
MA20 | 1.45▼ | 1.45▼ | 1.44▼ | 1.26▲ | 1.64▼ |
MA50 | 1.45▼ | 1.44▼ | 1.39▲ | 1.50▼ | 2.47▼ |
MA100 | 1.44▼ | 1.37▲ | 1.29▲ | 1.70▼ | 2.43▼ |
MA200 | 1.43▲ | 1.27▲ | 1.33▲ | 2.32▼ | 7.12▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | -0.001▼ | -0.005▼ | 0.043▲ | 0.011▲ |
RSI | 42.668▼ | 47.464▼ | 50.394▲ | 54.629▲ | 40.031▼ |
STOCH | 45.833 | 69.737 | 68.552 | 85.742▲ | 23.359 |
WILL %R | -100.000▼ | -45.000 | -41.667 | -17.500▲ | -55.814 |
CCI | -119.149▼ | -5.263 | 4.612 | 96.741 | -34.772 |
CDL | $ADCT Doji Candlestick Pattern Detected | Set Alert |
Monday, April 28, 2025 07:00 AM
ADC Therapeutics SA (ADCT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus ...
|
Monday, April 28, 2025 04:00 AM
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced data from preclinical studies of three exatecan-based ...
|
Monday, April 28, 2025 04:00 AM
LAUSANNE, Switzerland, April 28, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.43 | 1.48 | 1.3679 | 1.43 | 200,740 |
30/04/25 | 1.40 | 1.48 | 1.3505 | 1.43 | 205,103 |
29/04/25 | 1.41 | 1.46 | 1.41 | 1.43 | 152,980 |
28/04/25 | 1.46 | 1.50 | 1.365 | 1.46 | 410,037 |
25/04/25 | 1.35 | 1.355 | 1.29 | 1.33 | 139,156 |
24/04/25 | 1.34 | 1.36 | 1.32 | 1.36 | 180,010 |
23/04/25 | 1.28 | 1.34 | 1.27 | 1.29 | 399,220 |
22/04/25 | 1.25 | 1.26 | 1.20 | 1.23 | 334,408 |
21/04/25 | 1.21 | 1.26 | 1.20 | 1.23 | 266,947 |
17/04/25 | 1.16 | 1.24 | 1.14 | 1.21 | 165,658 |
|
|
||||
|
|
||||
|
|